在怀孕期间管理心房的挑战
Fabiana Lucà1, Fabrizio Oliva2, Maurizio Giuseppe Abrignani3
1Cardiology Department, Grande Ospedale Metropolitano, GOM, AO Bianchi Melacrino Morelli, 89124 Reggio Calabria, Italy.
Reviews in cardiovascular medicine
|July 30, 2024
概括
在怀孕期间管理心房动 (AF) 需要仔细评估孕产妇和胎儿的风险. 电动心脏转换和β-阻断剂是首选的,而导管切除不建议.
科学领域:
- 心脏病学 心脏病学
- 孕产妇和胎儿医学 孕产妇和胎儿医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 怀孕与心房 (AF) 的发病率增加有关,特别是在老年母亲或有结构性心脏病的母亲身上.
- 血栓塞栓症是AF孕妇患者的重大风险,需要早期诊断和治疗.
- 目前的血栓塞栓风险评分未经验证,无法预测怀孕中风,这使管理决策复杂化.
研究的目的:
- 审查在怀孕期间管理心房的挑战和当前治疗策略.
- 评估与抗失常药和抗凝药使用相关的孕产妇和胎儿风险.
- 提供关于孕妇AF最安全,最有效的治疗方法的指导.
主要方法:
- 现有研究的文献综述和关于怀孕期间AF管理的临床指南.
- 对各种抗心律失常和抗凝药疗法的孕产妇和胎儿安全概况的分析.
- 评估不同节奏和节奏控制策略的有效性.
主要成果:
- 电动心脏转换是血液动力学不稳定的AF孕妇患者最安全和最有效的治疗方法.
- 贝塔选择性阻断剂是速率控制的第一线选择.
- 如果其他方法失败,可以考虑使用抗节律药物 (flecainide,propafenone,sotalol) 来控制节律;不建议使用AF导管切除.
结论:
- 怀孕期间AF的治疗策略必须平衡有效性与孕产妇和胎儿的安全性,需要仔细的个人评估.
- 多学科的"怀孕-心脏团队"方法可以改善患者的治疗结果.
- 需要进一步的研究,以建立最佳的治疗指南在怀孕期间AF.
相关概念视频
01:28Disturbances in Heart Rhythm
927
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
927
01:31Adrenergic Antagonists: ɑ and β-Receptor Blockers
429
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
429
01:20Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
812
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
812
01:22Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.3K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.3K
01:24Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
727
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
727
01:12Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
952
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
952